
NVAX vs MESO
$NVAX vs $MESO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
NVAX vs MESO: the quick read
- ·MESO is the larger company by market cap ($1.83B vs $1.73B).
- ·NVAX has been more active on our scanner (160 vs 9 alerts in 30 days).
- ·NVAX has the smaller float (150.2M vs 889.2M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·NVAX draws far more of our scanner's attention, 160 unusual-volume alerts in 30 days against 9, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 6% of each other on market cap, which makes the rest of this table the interesting part.
- ·NVAX pays a dividend and MESO does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing NVAX and MESO on TheDesperateTrader.
- Is NVAX or MESO the better stock?
- "Better" depends on your goal, and these two are not alike. MESO is the larger company by market cap ($1.83B vs $1.73B). NVAX has been more active on our scanner (160 vs 9 alerts in 30 days). NVAX has the smaller float (150.2M vs 889.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between NVAX and MESO?
- The differences that matter: they are not in the same business - NVAX is biological products, (no diagnostic substances) and MESO is biological products, (no diagnostic substances); they are similar in size ($1.73B vs $1.83B); they trade at very different share prices ($10.49 vs $14.08); NVAX sits at 74% of its 52-week range against 12% for MESO; only NVAX pays a dividend; our scanner flagged NVAX 160 times in the last 30 days against 9 for MESO. Everything above is measured from the latest completed session and SEC filings.
- Which of NVAX and MESO is more active right now?
- Right now NVAX is at about 0.7x its normal volume and MESO is at about 1.3x, so MESO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading NVAX or MESO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore NVAX and MESO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.